Zobrazeno 1 - 10
of 42
pro vyhledávání: '"M.J. Ostrowski"'
Autor:
M.J. Ostrowski, Bridget T. Hill, F.J.F. Madden, P.A. Lawton, Margaret F. Spittle, K.D. Macrae, A. Folkes, Teresa E Young
Publikováno v:
Clinical Oncology. 5:80-84
Between July 1985 and December 1987, 87 patients with advanced breast carcinoma were randomized to receive single agent doxorubicin (70 mg/m2), epirubicin (70 mg/m2) or mitozantrone (14 mg/m2) at 3-weekly intervals. The patients had received no previ
Publikováno v:
Clinical Oncology. 5:25-29
A multicentre Phase II study of epirubicin has been performed in patients with measurable or evaluable recurrent or metastatic transitional cell bladder cancer. Epirubicin was given intravenously every 3 weeks at a dose of 100 mg/m 2 .. An objective
Publikováno v:
Clinical Oncology. 2:163-167
Four patients with seminoma of the testis and coexisting horseshoe kidney are presented. Three patients had stage one disease, which would conventionally be managed by abdominal nodal irradiation. However, because of the risk of radiation nephritis,
Autor:
P Harper, V Nagund, M.J Ostrowski, David E. Neal, J. Levay, A Robinson, R Ravi, B Sizer, R. T. D. Oliver, M.V. Williams, J. Ong, Jonathan Shamash
Publikováno v:
Scopus-Elsevier
Objectives To study survival and late events after adjuvant chemotherapy in Stage 1 nonseminoma. Methods From 1978 to 1986, all patients had surveillance. From 1986, adjuvant chemotherapy (initially a 3-day regimen of etoposide, bleomycin, and cispla
Autor:
H.F. Hope-Stone, W.R. Pratt, J.Y.H. Ong, T. Mott, H. Baille-Johnson, C.R. Wiltshire, A.W. Jackson, M.V. Williams, R.T.D. Oliver, C.W.L. Trask, P.M. Edmonds, M.J. Ostrowski
Publikováno v:
International journal of radiation oncology, biology, physics. 29(1)
Purpose : Underpinned by increased confidence in cure of metastatic seminoma by chemotherapy during the past 12 years, three management strategies for Stage I seminoma have been evaluated by six collaborating centers within the Anglian Germ Cell Tumo
Autor:
M.J. Ostrowski
Publikováno v:
Clinical Oncology. 3:154
Autor:
M.J. Ostrowski, K.D. Macrae, Thelma D. Bates, N.T Nicol, Bridget T. Hill, W. M. C. Martin, G.A. Edelstyn, Margaret F Spittle
Publikováno v:
European Journal of Cancer and Clinical Oncology. 23:1155-1162
A prospective, multicentre trial was conducted in 262 patients with advanced breast cancer randomized to receive every 3 weeks either: (i) a single five-drug combination of adriamycin (50 mg), vincristine (1.5 mg) and 5-fluorouracil (750 mg) given in
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 14(1)
Fifty-eight patients with malignant pleural effusions were entered into a prospectively randomized clinical trial comparing the efficacy of a local instillation of bleomycin or corynebacterium parvum (C. parvum) in controlling fluid reaccumulation af
Publikováno v:
The Lancet. 311:1043-1044
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.